FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

22192002: Salicylamide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
37255011 Salicylamide en Synonym Active Entire term case insensitive SNOMED CT core module
751572014 Salicylamide (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Salicylamide Is a Salicylate false Inferred relationship Existential restriction modifier
Salicylamide Is a Analgesic AND antipyretic false Inferred relationship Existential restriction modifier
Salicylamide Is a Salicylate false Inferred relationship Existential restriction modifier
Salicylamide Is a Non-steroidal anti-inflammatory agent true Inferred relationship Existential restriction modifier
Salicylamide Is a Substance with salicylamide structure true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Salicylamide measurement Has measured component False Salicylamide Inferred relationship Existential restriction modifier
Salicylamide measurement Component True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient False Salicylamide Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has active ingredient False Salicylamide Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 250 milligram and salicylamide 600 milligram/1 each conventional release oral tablet Has active ingredient False Salicylamide Inferred relationship Existential restriction modifier
Product containing paracetamol and salicylamide Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing paracetamol and phenyltoloxamine citrate and salicylamide Has active ingredient False Salicylamide Inferred relationship Existential restriction modifier
Product containing salicylamide Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing caffeine and paracetamol and salicylamide Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel Has active ingredient False Salicylamide Inferred relationship Existential restriction modifier
Product containing benzocaine and salicylamide Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Ethenzamide Is a False Salicylamide Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 250 milligram and salicylamide 600 milligram/1 each conventional release oral tablet Has basis of strength substance True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 250 milligram and salicylamide 600 milligram/1 each conventional release oral tablet Has active ingredient False Salicylamide Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 250 milligram and salicylamide 600 milligram/1 each conventional release oral tablet Has basis of strength substance False Salicylamide Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has active ingredient False Salicylamide Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has basis of strength substance False Salicylamide Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has basis of strength substance False Salicylamide Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient False Salicylamide Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has basis of strength substance False Salicylamide Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 250 milligram and salicylamide 600 milligram/1 each conventional release oral tablet Has precise active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has precise active ingredient False Salicylamide Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has precise active ingredient False Salicylamide Inferred relationship Existential restriction modifier 3
Product containing paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form) Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing paracetamol and phenyltoloxamine and salicylamide Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel Has precise active ingredient False Salicylamide Inferred relationship Existential restriction modifier 2
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel Has basis of strength substance False Salicylamide Inferred relationship Existential restriction modifier 2
Product containing benzocaine and salicylamide in cutaneous dose form (medicinal product form) Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing paracetamol and salicylamide in oral dose form (medicinal product form) Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Salicylamide + Benzocaine Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing only caffeine and paracetamol and salicylamide (medicinal product) Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing only paracetamol and salicylamide (medicinal product) Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing only paracetamol and phenyltoloxamine and salicylamide (medicinal product) Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing only salicylamide (medicinal product) Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing only benzocaine and salicylamide in cutaneous dose form (medicinal product form) Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form) Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing only paracetamol and salicylamide in oral dose form (medicinal product form) Has active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Salicylanilide Is a False Salicylamide Inferred relationship Existential restriction modifier
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel Has basis of strength substance True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel Has precise active ingredient True Salicylamide Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has basis of strength substance True Salicylamide Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has precise active ingredient True Salicylamide Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has basis of strength substance True Salicylamide Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has precise active ingredient True Salicylamide Inferred relationship Existential restriction modifier 2
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel Has active ingredient False Salicylamide Inferred relationship Existential restriction modifier
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel Has active ingredient False Salicylamide Inferred relationship Existential restriction modifier
Intralgin gel (3M Health Care Ltd, Pharmaceuticals Division) Has active ingredient False Salicylamide Inferred relationship Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram Has active ingredient False Salicylamide Inferred relationship Existential restriction modifier
Intralgin gel (3M Health Care Ltd, Pharmaceuticals Division) 50 gram Has active ingredient False Salicylamide Inferred relationship Existential restriction modifier
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel Has specific active ingredient True Salicylamide Inferred relationship Existential restriction modifier
Intralgin gel (3M Health Care Ltd, Pharmaceuticals Division) 50 gram Has specific active ingredient True Salicylamide Inferred relationship Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram Has specific active ingredient True Salicylamide Inferred relationship Existential restriction modifier
Intralgin gel (3M Health Care Ltd, Pharmaceuticals Division) Has specific active ingredient True Salicylamide Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start